News Digest
CAC2 Childhood Cancer Community News Digest (August 15-28)
Assorted News from the Last Two Weeks: The Food and Drug Administration (FDA) approved Imbruvica (ibrutinib) for the treatment of children aged 1 year or
August 29, 2022
No Comments
